Coagulation tenase and prothrombinase complexes (Tenase and prothrombinase complexes)

The coagulation tenase and prothrombinase complexes are multi-component enzyme assemblies that form on the surface of activated platelets to drive the coagulation cascade (Mann et al., 2003, Arterioscler Thromb Vasc Biol). The intrinsic tenase complex consists of activated Factor IX (FIXa) and its cofactor, activated Factor VIII (FVIIIa), which together catalyze the conversion of Factor X to Factor Xa. The prothrombinase complex is composed of activated Factor X (FXa) and its cofactor, activated Factor Va (FVa), which converts prothrombin into thrombin (Heemskerk et al., 2013, Thromb Res). Both complexes require calcium ions and a negatively charged phospholipid surface, typically provided by phosphatidylserine (PS) exposed on the outer leaflet of activated platelet membranes (Zwaal & Schroit, 1997, Blood). This localization concentrates the reactants, accelerating thrombin generation by several orders of magnitude compared to reactions in solution. Dysregulation of these complexes is central to thrombotic disorders, such as deep vein thrombosis and myocardial infarction, as well as bleeding disorders like hemophilia (Dahlbäck, 2000, Lancet). Pharmacological targeting of these complexes, particularly through Factor Xa inhibitors like rivaroxaban or indirect inhibitors like heparin, is a cornerstone of anticoagulant therapy to prevent and treat thromboembolic events (Bauer, 2011, Hematology Am Soc Hematol Educ Program).

Other names

Intrinsic tenase complexProthrombinase complexXase complexPlatelet procoagulant surfaceFactor IXa-VIIIa complexFactor Xa-Va complexProcoagulant membrane-bound complexes

Inhibition of the enzymatic components (Factor Xa or Factor IXa) or their assembly on the phospholipid surface to prevent the conversion of prothrombin to thrombin.